Canada markets open in 6 hours 28 minutes

Appili Therapeutics Inc. (APLI.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.04000.0000 (0.00%)
At close: 12:32PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 4.85M
Enterprise Value 12.26M
Trailing P/E N/A
Forward P/E 2.38
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.22
Price/Book (mrq)N/A
Enterprise Value/Revenue 10.66
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.14
52-Week Change 314.29%
S&P500 52-Week Change 324.71%
52 Week High 30.0800
52 Week Low 30.0250
50-Day Moving Average 30.0380
200-Day Moving Average 30.0369

Share Statistics

Avg Vol (3 month) 3204.47k
Avg Vol (10 day) 3107.93k
Shares Outstanding 5121.27M
Implied Shares Outstanding 6121.27M
Float 8106.83M
% Held by Insiders 10.06%
% Held by Institutions 111.84%
Shares Short (May 31, 2024) 447.05k
Short Ratio (May 31, 2024) 40.67
Short % of Float (May 31, 2024) 4N/A
Short % of Shares Outstanding (May 31, 2024) 40.04%
Shares Short (prior month Apr 30, 2024) 440.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-401.26%

Management Effectiveness

Return on Assets (ttm)-215.78%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)1.15M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -7.85M
Net Income Avi to Common (ttm)-5.34M
Diluted EPS (ttm)-0.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)602.88k
Total Cash Per Share (mrq)0
Total Debt (mrq)8.01M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.46
Book Value Per Share (mrq)-0.08

Cash Flow Statement

Operating Cash Flow (ttm)-3.12M
Levered Free Cash Flow (ttm)-4.25M